What are the main mechanisms of action and therapeutic effects of Mitotane?

Mitotane is a drug mainly used to treat adrenocortical cancer (ACC). Its unique mechanism of action makes it an important treatment for this disease. Mitotane is an adrenocortical toxic drug that can selectively destroy adrenocortical cells and inhibit the function of the adrenal cortex, thereby reducing the levels of excessive secretion of cortisol and other hormones. This property not only has anti-tumor effects, but also effectively controls the endocrine symptoms caused by adrenocortical cancer.

In terms of molecular mechanism, mitotane interferes with mitochondrial energy metabolism and steroid hormone synthesis by damaging the mitochondria of adrenocortical cells. Specifically, it damages the integrity of the mitochondrial membrane and inhibits the activity of key enzymes in cholesterol transport and steroid synthesis, leading to impaired adrenal cell function and apoptosis. This cytotoxic effect is selective for adrenocortical cancer cells and thus effectively inhibits tumor growth and spread.

The main clinical therapeutic effect of mitotane is reflected in two aspects: first, as an adjuvant treatment, the use of mitotane can significantly reduce the risk of recurrence in patients after surgical resection of adrenocortical cancer; second, for patients with unresectable or metastatic adrenocortical cancer, mitotane can help control tumor progression and relieve hormone-related symptoms, and improve the patient's quality of life. Because of its slow action, long-term medication and close monitoring of drug concentrations and side effects are usually required.

It is worth noting that mitotane has certain side effects, such as gastrointestinal discomfort, neurological symptoms, and liver function abnormalities, so regular clinical and laboratory monitoring is required during treatment. Doctors will adjust the dosage according to the patient's specific conditions to ensure that the drug works within the effective concentration range while minimizing adverse reactions. In general, mitotane has become one of the important drugs in the treatment of adrenocortical cancer due to its unique mechanism of action and significant therapeutic effect.

Reference materials:https://go.drugbank.com/drugs/DB00648